AOTI’s topical wound oxygen (TWO2) therapy study shows superior durable healing of chronic wounds in 3,126 patients: Oceanside, California Wednesday, April 29, 2026, 18:00 Hrs [ ...
Pharma, healthcare deals hold steady in Q1 2026 at US$ 1.9 bn; large-ticket slowdown weighs on values: Grant Thornton Bharat: Our Bureau, Bengaluru Wednesday, April 29, 2026, 16:2 ...
S L Raheja Hospital Mumbai launches of enhanced diagnostics and orthorobo care to mark 45 years of clinical excellence: Our Bureau, Mumbai Wednesday, April 29, 2026, 17:15 Hrs [IS ...
ISMOCD with AMC and Envu India helps unite India’s public health leadership to advance urban vector-borne disease control: Our Bureau, Bengaluru Wednesday, April 29, 2026, 12:15 ...
TytoCare receives FDA De Novo classification for the first model of Tyto Insights for ENT Suite: New York Wednesday, April 29, 2026, 13:00 Hrs [IST] TytoCare, a virtual care compa ...
Boston Cell Standards enters into final phase of US FDA’s MDDT programme to qualify first-in-industry to standardize cancer diagnostic assays: Boston Wednesday, April 29, 2026, ...
Ferrotec introduces Ferrobeads DNA/RNA isolation kits for high-efficiency nucleic acid extraction: Livermore, California Wednesday, April 29, 2026, 13:30 Hrs [IST] Ferrotec (USA) ...
SRM Medical College Hospital and Research Centre Hosts “Illuminova ’26”: A futuristic UG research expo advancing healthcare with AI: Our Bureau, Bengaluru Wednesday, April 2 ...
Athulya Senior Care inks MoU with SingHealth to advance care, training and research collaboration: Our Bureau, Bengaluru Wednesday, April 29, 2026, 11:45 Hrs [IST] Athulya Senior ...
US FDA approves Apotex’s generic Infuvite paediatric injection, eligible for 180 day CGT exclusivity
US FDA approves Apotex’s generic Infuvite paediatric injection, eligible for 180 day CGT exclusivity: Weston, Florida Wednesday, April 29, 2026, 15:00 Hrs [IST] Apotex, in colla ...
Akso Health initiates world-class, proprietary Brain-Computer Interface R&D programme: Qingdao, China Wednesday, April 29, 2026, 14:00 Hrs [IST] Akso Health Group (AHG), formerly ...
AbbVie seeks US FDA approval for Skyrizi subcutaneous induction for adults with moderately to severely active Crohn's disease: North Chicago, Illinois Wednesday, April 29, 2026, 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results